EW
55
14
DTE
45
-2
L
55
-3
MRK
30
5
CFG
44
-4
NUE
43
-4
CA
32
-12
WYNN
30
-2
PCAR
50
-6
PFG
30
-3
TSN
30
-2
TMO
54
-2
ROK
54
2
RF
44
-4
HUM
31
-3
QCOM
53
-2
CSCO
64
3
CTSH
52
-4
EBAY
47
3
IPG
47
-2
EW
55
14
DTE
45
-2
L
55
-3
MRK
30
5
CFG
44
-4
NUE
43
-4
CA
32
-12
WYNN
30
-2
PCAR
50
-6
PFG
30
-3
TSN
30
-2
TMO
54
-2
ROK
54
2
RF
44
-4
HUM
31
-3
QCOM
53
-2
CSCO
64
3
CTSH
52
-4
EBAY
47
3
IPG
47
-2
Financhill
Back

CVR Partners LP 10K Form

Buy
56

UAN
CVR Partners LP

Last Price:
75.15
Seasonality Move:
13.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UAN News And Ratings

See the #1 stock for the next 7 days that we like better than UAN

UAN Financial Statistics

Sales & Book Value

Annual Sales: $681.48M
Cash Flow: $82.26M
Price / Cash Flow: 8.8
Annual Sales: $27.19
Price / Book: 2.78

Profitability

EPS (TTM): 4.97000
Net Income (TTM): $52.58M
Gross Margin: $232.46M
Return on Equity: 17.52%
Return on Assets: 5.35%

CVR Partners LP Earnings Forecast

Key CVR Partners LP Financial Ratios

  • The Gross Profit Margin over the past 16 years for UAN is 34.11%.
  • The Selling, General & Administrative Expenses for UAN have been equal to 4.33% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 16.62% of Operating Income.
  • The Net Earning history of UAN is 25.30% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 7 years.

CVR Partners LP Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Chemicals
Sector: Materials
Current Symbol: UAN
CUSIP: 126633
Website: cvrpartners.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.15
Quick Ratio: 1.39

Price-to-Earnings

Trailing P/E Ratio: 4.63
Forward P/E Ratio: 0

UAN Technical Analysis vs Fundamental Analysis

Buy
56
CVR Partners LP (UAN) is a Buy

Is CVR Partners LP a Buy or a Sell?

  • CVR Partners LP stock is rated a Buy
    The current CVR Partners LP [UAN] share price is $75.54. The Score for UAN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.